Hematopoietic stem cell transplantation in Oman

Bone Marrow Transplantation
D DennisonSs Ganguly

Abstract

Hematopoietic SCT (HSCT) is an integral part of the management of patients with hematologic disorders. The Sultanate of Oman, with a population of 2.3 million, has an HSCT program based in the Sultan Qaboos University (SQU) hospital. Initiated in 1995, this two-bed unit continues to be the only program in the country. Between June 1995 and August 2006, a total of 128 patients underwent HSCT in this center, averaging about 10-12 transplants per year. The median age of these patients was 11 years (2 months to 45 years). Hematologic malignancies (49%) and inherited disorders (42%) constituted the major transplant indications, whereas BM failure accounted for the remaining. The majority of transplants carried out so far have been HLA-matched sibling-donor allogeneic HSCTs. Among the inherited disorders, homozygous beta-thalassemia and primary immunodeficiency are important transplant indications in this center. The approximate cost of an uncomplicated transplant in this center is US$50,000. The success of this program has now led to the initiation of a new and larger HSCT complex to provide the opportunity for more patients to benefit from this treatment modality within the country.

References

Jul 21, 1998·Annals of the New York Academy of Sciences·G LucarelliD Gaziev
Jan 10, 2002·Bone Marrow Transplantation·A M BolingerM J Cowan
Dec 21, 2004·American Journal of Hematology·Shanmugakonar MuralitharanRajagopal Krishnamoorthy

❮ Previous
Next ❯

Citations

Jan 30, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Mahmoud AljurfHassan El Solh
Feb 4, 2012·Annals of the New York Academy of Sciences·Saleh Al-Muhsen, Zobaida Alsum
Sep 11, 2014·Pharmacology & Therapeutics·Luc RochetteCatherine Vergely
Aug 15, 2009·Current Opinion in Hematology·Alois Gratwohl, Helen Baldomero
Dec 19, 2016·Transplantation Direct·Abdallah S Daar, Nabil Mohsin Al Lawati
Dec 14, 2018·Journal of Global Health·Shadi SalehAbla Mehio Sibai
Dec 31, 2020·Journal of Fungi·Abdullah M S Al-HatmiDavid W Denning

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

© 2022 Meta ULC. All rights reserved